{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:22:48Z","timestamp":1789917768399,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":2655,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1074\/jbc.m113.483800","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T03:51:20Z","timestamp":1368589880000},"page":"18335-18344","source":"Crossref","is-referenced-by-count":18,"title":["New Approaches to Prevent LEOPARD Syndrome-associated Cardiac Hypertrophy by Specifically Targeting Shp2-dependent Signaling"],"prefix":"10.1016","volume":"288","author":[{"given":"Christine","family":"Schramm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Krenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.483800_bib1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy. From genetics to treatment","volume":"40","author":"Marian","year":"2010","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1074\/jbc.M113.483800_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archpedi.1969.02100030654006","article-title":"Multiple lentigenes syndrome","volume":"117","author":"Gorlin","year":"1969","journal-title":"Am. J. Dis. Child"},{"key":"10.1074\/jbc.M113.483800_bib3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S104795110800320X","article-title":"A standard echocardiographic and tissue Doppler study of morphological and functional findings in children with hypertrophic cardiomyopathy compared to those with left ventricular hypertrophy in the setting of Noonan and LEOPARD syndromes","volume":"18","author":"Cerrato","year":"2008","journal-title":"Cardiol. Young"},{"key":"10.1074\/jbc.M113.483800_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.M113.483800_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J. Med. Genet"},{"key":"10.1074\/jbc.M113.483800_bib6","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","article-title":"The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling","volume":"302","author":"Schramm","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.M113.483800_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.483800_bib8","doi-asserted-by":"crossref","first-page":"H1531","DOI":"10.1152\/ajpheart.00216.2011","article-title":"LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt\/GSK-3\u03b2\/\u03b2-catenin signaling","volume":"301","author":"Ishida","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol"},{"key":"10.1074\/jbc.M113.483800_bib9","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/MCB.00646-09","article-title":"Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase\/AKT\/glycogen synthase kinase 3\u03b2 signaling","volume":"30","author":"Edouard","year":"2010","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/147323000803600424","article-title":"Negative inotropic effect of rapamycin on isolated human cardiomyocytes","volume":"36","author":"M\u00f6llmann","year":"2008","journal-title":"J. Int. Med. Res"},{"key":"10.1074\/jbc.M113.483800_bib11","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00246-009-9473-7","article-title":"PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy. What is the link?","volume":"30","author":"Faienza","year":"2009","journal-title":"Pediatr. Cardiol"},{"key":"10.1074\/jbc.M113.483800_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00431-005-1679-y","article-title":"A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy","volume":"164","author":"Takahashi","year":"2005","journal-title":"Eur. J. Pediatr"},{"key":"10.1074\/jbc.M113.483800_bib13","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.483800_bib14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI30756","article-title":"Mediating ERK 1\/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome","volume":"117","author":"Nakamura","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M113.483800_bib15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.RES.0000023201.41774.EA","article-title":"GFP-FRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes","volume":"90","author":"Heidkamp","year":"2002","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M113.483800_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.RES.0000186194.06514.b0","article-title":"Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1\/2 signaling","volume":"97","author":"Krenz","year":"2005","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M113.483800_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.RES.0000041029.97988.E9","article-title":"Ras\/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes","volume":"91","author":"Wang","year":"2002","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M113.483800_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib19","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gad.1089403","article-title":"Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2","volume":"17","author":"Peng","year":"2003","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M113.483800_bib20","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/MCB.25.23.10407-10418.2005","article-title":"Dosage-dependent effects of Akt1\/protein kinase B\u03b1 (PKB\u03b1) and Akt3\/PKB\u03b3 on thymus, skin, and cardiovascular and nervous system development in mice","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib21","doi-asserted-by":"crossref","first-page":"8042","DOI":"10.1128\/MCB.00722-06","article-title":"Life with a single isoform of Akt. Mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies","volume":"26","author":"Dummler","year":"2006","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yjmcc.2011.03.001","article-title":"Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes","volume":"51","author":"Dhandapany","year":"2011","journal-title":"J. Mol. Cell Cardiol"},{"key":"10.1074\/jbc.M113.483800_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/hmg\/ddn336","article-title":"Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development","volume":"18","author":"Oishi","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M113.483800_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.devcel.2010.03.009","article-title":"Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis","volume":"18","author":"Stewart","year":"2010","journal-title":"Dev. Cell"},{"key":"10.1074\/jbc.M113.483800_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.M113.483800_bib26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.483800_bib27","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.1073\/pnas.0710468105","article-title":"Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking","volume":"105","author":"Hellmuth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.483800_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/15216540701694245","article-title":"Focal adhesion kinase. An essential kinase in the regulation of cardiovascular functions","volume":"59","author":"Vadali","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1074\/jbc.M113.483800_bib29","doi-asserted-by":"crossref","first-page":"33024","DOI":"10.1074\/jbc.M313265200","article-title":"Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase\/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a \u03b2 1 integrin viability signaling pathway","volume":"279","author":"Xia","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.483800_bib30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1161\/CIRCRESAHA.109.195941","article-title":"Transient expression of FRNK reveals stage-specific requirement for focal adhesion kinase activity in cardiac growth","volume":"104","author":"DiMichele","year":"2009","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.M113.483800_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/dvg.20650","article-title":"Focal adhesion kinase is essential for cardiac looping and multichamber heart formation","volume":"48","author":"Doherty","year":"2010","journal-title":"Genesis"},{"key":"10.1074\/jbc.M113.483800_bib32","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1073\/pnas.0802319105","article-title":"Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice","volume":"105","author":"Peng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.483800_bib33","doi-asserted-by":"crossref","first-page":"32841","DOI":"10.1074\/jbc.M513087200","article-title":"Akt2 regulates cardiac metabolism and cardiomyocyte survival","volume":"281","author":"DeBosch","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.483800_bib34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","article-title":"Akt1 is required for physiological cardiac growth","volume":"113","author":"DeBosch","year":"2006","journal-title":"Circulation"},{"key":"10.1074\/jbc.M113.483800_bib35","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB \u03b2)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.M113.483800_bib36","doi-asserted-by":"crossref","first-page":"38349","DOI":"10.1074\/jbc.C100462200","article-title":"Akt1\/PKB\u03b1 is required for normal growth but dispensable for maintenance of glucose homeostasis in mice","volume":"276","author":"Cho","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.483800_bib37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1124\/mol.106.025536","article-title":"Discovery of a novel shp2 protein tyrosine phosphatase inhibitor","volume":"70","author":"Chen","year":"2006","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.483800_bib38","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/onc.2011.436","article-title":"Dynamin 2 mediates PDGFR\u03b1-SHP-2-promoted glioblastoma growth and invasion","volume":"31","author":"Feng","year":"2012","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.483800_bib39","doi-asserted-by":"crossref","first-page":"33155","DOI":"10.1074\/jbc.M805138200","article-title":"Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase","volume":"283","author":"Jakob","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.483800_bib40","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome. Consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.M113.483800_bib41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cell.2011.07.020","article-title":"Global proteomic assessment of the classical protein-tyrosine phosphatome and \u201cRedoxome.\u201d","volume":"146","author":"Karisch","year":"2011","journal-title":"Cell"},{"key":"10.1074\/jbc.M113.483800_bib42","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1128\/MCB.23.21.7875-7886.2003","article-title":"Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling","volume":"23","author":"Agazie","year":"2003","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbamcr.2005.11.013","article-title":"Mutation of Thr-466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant","volume":"1763","author":"Merritt","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.483800_bib44","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1128\/MCB.19.4.3125","article-title":"Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility","volume":"19","author":"Ma\u00f1es","year":"1999","journal-title":"Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.483800_bib45","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1093\/emboj\/cdg492","article-title":"Force-dependent integrin-cytoskeleton linkage formation requires down-regulation of focal complex dynamics by Shp2","volume":"22","author":"von Wichert","year":"2003","journal-title":"EMBO J"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820458223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820458223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.483800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T14:48:20Z","timestamp":1641307700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820458223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0021925820458223"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.483800","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}